Novel approaches in CRISPR/Cas12a-based sensing for HCC diagnosis - A review (2020–2025)

Cunhong Cen, Xiyu Liu, Wei He, Xiaohong Tan, Guiyin Li, Na Jintong

Open source

DOI
10.1016/j.jpba.2025.116878
Published
2025-09
Container
Journal of Pharmaceutical and Biomedical Analysis
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jpba.2025.116878,
  title = {Novel approaches in CRISPR/Cas12a-based sensing for HCC diagnosis - A review (2020–2025)},
  author = {Cunhong Cen and Xiyu Liu and Wei He and Xiaohong Tan and Guiyin Li and Na Jintong},
  year = {2025},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  doi = {10.1016/j.jpba.2025.116878},
  url = {https://doi.org/10.1016/j.jpba.2025.116878}
}

RIS

TY  - JOUR
TI  - Novel approaches in CRISPR/Cas12a-based sensing for HCC diagnosis - A review (2020–2025)
AU  - Cunhong Cen
AU  - Xiyu Liu
AU  - Wei He
AU  - Xiaohong Tan
AU  - Guiyin Li
AU  - Na Jintong
PY  - 2025
JO  - Journal of Pharmaceutical and Biomedical Analysis
DO  - 10.1016/j.jpba.2025.116878
UR  - https://doi.org/10.1016/j.jpba.2025.116878
ER  - 

APA

Cen, C., Liu, X., He, W., Tan, X., Li, G., & Jintong, N. (2025). Novel approaches in CRISPR/Cas12a-based sensing for HCC diagnosis - A review (2020–2025). Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2025.116878

Source records